Microviable Therapeutics, through our CEO Rafael Martínez Permuy, was part of the “Gut Microbiota for Health World Summit” (#GMFH2020) that was held on March 7 and 8 in Madrid, a great international event on microbiota that has recorded 200 attendees in person plus some others by videoconference (videoconference due to travel restrictions).
“An excellent opportunity to learn about new discoveries about the role of the gut microbiome in health and disease and how they translate or translate into clinical practice for the benefit of health professionals and patients”. Said Harry Sokol, Co-Chair of the Scientific Committee.
With lectures given by experts such as Francisco Guarner, Colin Hill, Kevin Whelan, Hana Kahleova, Dirk Haller, Kathy McCoy, Gérard Eberl, Moran Yassour, Paul W. O´Toole, Purna Kashyap, Alberto Caminero, Emily Davenport, Eran Segal, Ran Blekhman, Jessica Allegretti, Emily Balskus, Michael Scharl, John Cryan, Jonathan Lynch, Joel Dore, Rinse K. Weersma, Athanasios Typas y David Riglar
European Society of Neurogastroenterology and Motility (ESNM), American Gastroenterological Association (AGA) and American Neurogastroenterology and Motility Society
